Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia

NCT00306202 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Dasatinib
DRUG: Dasatinib
DRUG: Dasatinib

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]